Yoga for Young Women With Depression
Yoga-based Therapy for Young Women With Depression: a Randomized Controlled Trial
1 other identifier
interventional
170
1 country
1
Brief Summary
The investigators examine whether adding yoga-based therapy (YBT) to treatment as usual (TAU) for young adult women (age 18-34 years) with a primary diagnosis of MDD leads to (1) greater reductions in symptoms and (2) greater cost-effectiveness in that the economic benefits of adding YBT to TAU outweigh the costs.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable major-depressive-disorder
Started Dec 2016
Typical duration for not_applicable major-depressive-disorder
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
December 16, 2016
CompletedFirst Submitted
Initial submission to the registry
November 2, 2017
CompletedFirst Posted
Study publicly available on registry
January 2, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 16, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
December 16, 2019
CompletedFebruary 5, 2018
February 1, 2018
2 years
November 2, 2017
February 2, 2018
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Change in Hamilton Depression Rating Scales (from baseline to 10-15 weeks post baseline, 6-month follow-up and 12-month follow-up)
Clinician-administered. Hamilton Depression Rating Scales: to assess symptoms of depression; total scores from 0-52; higher value represent more symptoms of depression.
Baseline, 10-15 weeks post baseline, 6 and 12 months follow-up
Change in Depression scale of Depression Anxiety Stress Scales (from baseline to 10-15 weeks post baseline, 6-month follow-up and 12-month follow-up)
Self-report. Depression Anxiety Stress Scales: to assess symptoms of depression with total possible score of 0-21; higher values represent more depression
Baseline, 10-15 weeks post baseline, 6 and 12 months follow-up
Secondary Outcomes (15)
Structured clinical interview for DSM-IV
12 months follow-up
Change in Anxiety scale of Depression Anxiety Stress Scales (from baseline to 10-15 weeks post baseline, 6-month follow-up and 12-month follow-up)
Baseline, 10-15 weeks post baseline, 6 and 12 months follow-up
Change in Stress scale of Depression Anxiety Stress Scales (from baseline to 10-15 weeks post baseline, 6-month follow-up and 12-month follow-up)
Baseline, 10-15 weeks post baseline, 6 and 12 months follow-up
Healthcare use with healthcare consumption scale (from baseline to 10-15 weeks post baseline, 6-month follow-up and 12-month follow-up)
Baseline, 10-15 weeks post baseline, 6 and 12 months follow-up
Health-related quality of life with EQ-5D-5L (from baseline to 10-15 weeks post baseline, 6-month follow-up and 12-month follow-up)
Baseline, 10-15 weeks post baseline, 6 and 12 months follow-up
- +10 more secondary outcomes
Study Arms (2)
Treatment as usual + Yoga-based therapy
EXPERIMENTALThe yoga-based therapy (YBT) group will receive YBT in addition to treatment-as-usual (TAU). YBT will be administered with a manualized protocol and delivered in a group format consisting of nine weekly sessions of 1,5 hours. Group sessions consist of hatha yoga practices of physical postures, breathing practices, and meditation. Each session has a different theme. The practices will primarily consist of yoga exercises (80%) and meditation (e.g., breathing practices) (20%). Between sessions, participants complete an online module with additional psychoeducation and a practice video to encourage home practice for 30-45 minutes a day. YBT will be delivered by a psychologist who is also a trained yoga teacher.
Treatment as usual
OTHERThe treatment as usual (TAU)-only condition will consist of interventions recommended by the Dutch guidelines for depression. These include the combination of pharmacotherapy (antidepressant medications) and psychotherapy (e.g., cognitive behavioral therapy \[CBT\], interpersonal psychotherapy). Lentis mental health clinicians will administer TAU. In order to improve ability to interpret study results, the investigators will record frequency, content (e.g., cognitive restructuring), format (group versus individual), and intensity of contact within TAU. Such quantification of TAU will allow us to address alternative explanations (e.g., contact time) in the case of positive results for YBT.
Interventions
Eligibility Criteria
You may qualify if:
- Primary diagnosis of a major depressive disorder.
- Age ≥ 18 and ≤ 34.
- Ability to fluently read, write, and speak Dutch.
You may not qualify if:
- Current diagnoses of bipolar disorder and substance dependence.
- Current psychotic symptoms.
- Active suicidality.
- Unwilling or inability to attend to 9 weekly sessions of yoga.
- Regular yoga practice (on average over the past 6 months, 30 or more minutes per week).
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of Groningenlead
- Lentis Psychiatric Institutecollaborator
- ZonMw: The Netherlands Organisation for Health Research and Developmentcollaborator
- Triodos Foundationcollaborator
Study Sites (1)
Lentis Psychiatric Institute
Groningen, 9725AG, Netherlands
Related Publications (1)
Vollbehr NK, Hoenders HJR, Bartels-Velthuis AA, Nauta MH, Castelein S, Schroevers MJ, Stant AD, Albers CJ, de Jong PJ, Ostafin BD. Mindful yoga intervention as add-on to treatment as usual for young women with major depressive disorder: Results from a randomized controlled trial. J Consult Clin Psychol. 2022 Dec;90(12):925-941. doi: 10.1037/ccp0000777.
PMID: 36701531DERIVED
Related Links
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Brian D. Ostafin
University of Groningen
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Masking Details
- The project uses a blinded rater to assess the primary outcome measure of symptoms of depression
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor
Study Record Dates
First Submitted
November 2, 2017
First Posted
January 2, 2018
Study Start
December 16, 2016
Primary Completion
December 16, 2018
Study Completion
December 16, 2019
Last Updated
February 5, 2018
Record last verified: 2018-02